Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Cell Death Discovery|December 30, 2025
Vascular smooth muscle cell metabolic reprogramming and phenotypic remodeling in atherosclerosisZhenyue Fu, Shuo Yang, Xindi Chang, et al.
International Immunopharmacology|November 22, 2024
Taoren Honghua Decoction alleviates atherosclerosis by inducing autophagy and inhibiting the PI3K-AKT signaling pathway to regulate cholesterol efflux and inflammatory responsesXindi Chang, Xiaoteng Feng, Sijin Li, et al.
Cell Death Discovery|May 1, 2024
The role of IFI16 in regulating PANoptosis and implication in heart diseasesXindi Chang, Bei Wang, Yingli Zhao, et al.
Frontiers in Pharmacology|October 27, 2023
Tanshinone IIA alleviates atherosclerosis in LDLR-/- mice by regulating efferocytosis of macrophagesJiarou Wang, Yifan Zhang, Xiaoteng Feng, et al.
Vascular Health and Risk Management|December 12, 2024
Association of Lactate with Risk of Cardiovascular Diseases: A Two-Sample Mendelian Randomization StudyXindi Chang, Wang Zheng, Yingli Zhao, et al.
Frontiers in Pharmacology|July 6, 2023
Pharmacological effects and mechanisms of paeonol on antitumor and prevention of side effects of cancer therapyXindi Chang, Xiaoteng Feng, Min Du, et al.
Scientific Reports|May 18, 2025
Identification of hub biomarkers in coronary artery disease patients using machine learning and bioinformatic analysesXindi Chang, Liyu Tao, Lulu Tian, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|September 7, 2024
Serum tsncRNAs reveals novel potential therapeutic targets of Salvianolic Acid B on atherosclerosisXindi Chang, Min Du, Jing Wei, et al.
Medicine|July 18, 2026
The bidirectional genetic causality between immunocyte phenotypes and dilated cardiomyopathy: A bidirectional Mendelian randomization studyWenshuai Feng, Xindi Chang, Qiaozhi Li, et al.
Vascular Health and Risk Management|April 20, 2026
Taoren Honghua Jian Regulate NLRP3 Inflammasome of Coronary Artery Disease Patients: A Multi-Center, Double-Blind, Randomized Controlled TrialMin Du, Xiaoteng Feng, Na Zhang, et al.
Pageof 2